Corvus Pharmaceuticals (CRVS) Q4 2024 Annual Earnings
CRVS·Reported March 25, 2025·After market close
Diluted EPS came in at $-0.18, missed the $-0.12 consensus by $0.06.
Diluted EPS
$-0.18missed by $0.06
Consensus: $-0.12
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Corvus Pharmaceuticals's Q4 2024 earnings report.
Corvus Pharmaceuticals (CRVS) reported Q4 2024 earnings on March 25, 2025 after market close.
Corvus Pharmaceuticals reported diluted EPS of $-0.18 for Q4 2024.
EPS missed the consensus estimate of $-0.12 by $0.06.
You can read the 10-K periodic report (0001558370-25-003621) directly on SEC EDGAR. The filing index links above go to sec.gov.